Hypoxic and redox inhibition of the human cardiac L-type Ca2+ channel

Adv Exp Med Biol. 2000:475:209-18. doi: 10.1007/0-306-46825-5_20.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 4-Chloromercuribenzenesulfonate / pharmacology
  • Calcium Channel Blockers / pharmacology
  • Calcium Channels, L-Type / genetics
  • Calcium Channels, L-Type / metabolism*
  • Cell Hypoxia / physiology
  • Cell Line
  • Dithiothreitol / pharmacology
  • Ethyl Methanesulfonate / analogs & derivatives
  • Ethyl Methanesulfonate / pharmacology
  • Humans
  • Mesylates / pharmacology
  • Myocardium / metabolism*
  • Oxidation-Reduction
  • Recombinant Proteins / antagonists & inhibitors
  • Recombinant Proteins / genetics
  • Recombinant Proteins / metabolism
  • Transfection

Substances

  • Calcium Channel Blockers
  • Calcium Channels, L-Type
  • Mesylates
  • Recombinant Proteins
  • methanethiosulfonate ethylammonium
  • (2-sulfonatoethyl)methanethiosulfonate
  • 4-Chloromercuribenzenesulfonate
  • Ethyl Methanesulfonate
  • Dithiothreitol